Evaluation of Interference Between Cell Phones and Implantable Cardioverter Defibrillators
NCT ID: NCT02330900
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2014-11-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Interference Between Bioelectrical Impedance Analysis and Implantable Cardioverter Defibrillators
NCT02349737
Safety of Smartphones Among Patients With Cardiac Implantable Electronic Devices
NCT01819896
Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices
NCT02252575
Safety of Screening Procedures With Hand-held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices
NCT01369706
Examination of Implant´s Safety in an Electronic and Magnetic Field Environment
NCT01626261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interference will be assessed by the presence of visible artefacts on the real-time electrogram, with ICD marker annotations showing atrial and/or ventricular sensed episodes. The outcome measure will be the number and proportion of patients who have electromagnetic interference of the ICD when exposed to cell phones.
The procedure will take approximately 5-10minutes, with reprogramming of the device at the end of the test. No further follow-up in the context of the study will be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Evaluation of interference
Study group
Exposure to cell phone interference of the ICD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Study group
Exposure to cell phone interference of the ICD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* inability to sign an informed consent
* pacemaker dependancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haran Burri, MD
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haran Burri, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Geneva
Geneva, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Burri H, Mondouagne Engkolo LP, Dayal N, Etemadi A, Makhlouf AM, Stettler C, Trentaz F. Low risk of electromagnetic interference between smartphones and contemporary implantable cardioverter defibrillators. Europace. 2016 May;18(5):726-31. doi: 10.1093/europace/euv374. Epub 2016 Feb 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-245
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.